Please login to the form below

Not currently logged in
Email:
Password:

Teprotumumab

This page shows the latest Teprotumumab news and features for those working in and with pharma, biotech and healthcare.

FDA approves Horizon's thyroid eye disease drug ahead of schedule

FDA approves Horizon's thyroid eye disease drug ahead of schedule

The US Food and Drug Administration (FDA) was due to deliver a verdict on Tepezza (teprotumumab-trbw) on 8 March. ... We believe teprotumumab may impact underlying mechanisms of fibrosis and could demonstrate utility beyond thyroid eye disease,

Latest news

  • Horizon looks bright as FDA panel backs eye drug teprotumumab Horizon looks bright as FDA panel backs eye drug teprotumumab

    took intravenous teprotumumab meeting the primary endpoint of a 2mm reduction in eyeball protrusion, compared to 9.5% of the control arm. ... Teprotumumab has breakthrough therapy, orphan drug and fast track designations from the FDA.

  • Horizon sunny as thyroid eye disease drug hits the mark Horizon sunny as thyroid eye disease drug hits the mark

    Eye specialist Raymond Douglas of Cedars-Sinai Medical Centre in the US, one of the principal investigators in the trial, said that the reduction in proptosis with teprotumumab was “unprecedented”. ... If approved, teprotumumab would give physicians

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics